World Health Organization (WHO) guidelines on use of medically important antimicrobials in food-producing animals

Author:

Aidara-Kane Awa,Angulo Frederick J.,Conly John M.,Minato YukiORCID,Silbergeld Ellen K.,McEwen Scott A.,Collignon Peter J., ,Balkhy Hanan,Collignon Peter,Conly John,Friedman Cindy,Hollis Aidan,Kariuki Samuel,Kwak Hyo-Sun,McEwen Scott,Moulin Gérard,Ngandjio Antoinette,Rollin Bernard,Rossi Flávia,Wallinga David

Abstract

Abstract Background Antimicrobial use in food-producing animals selects for antimicrobial resistance that can be transmitted to humans via food or other transmission routes. The World Health Organization (WHO) in 2005 ranked the medical importance of antimicrobials used in humans. In late 2017, to preserve the effectiveness of medically important antimicrobials for humans, WHO released guidelines on use of antimicrobials in food-producing animals that incorporated the latest WHO rankings. Methods WHO commissioned systematic reviews and literature reviews, and convened a Guideline Development Group (GDG) of external experts free of unacceptable conflicts-of-interest. The GDG assessed the evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, and formulated recommendations using a structured evidence-to-decision approach that considered the balance of benefits and harms, feasibility, resource implications, and impact on equity. The resulting guidelines were peer-reviewed by an independent External Review Group and approved by the WHO Guidelines Review Committee. Results These guidelines recommend reductions in the overall use of medically important antimicrobials in food-producing animals, including complete restriction of use of antimicrobials for growth promotion and for disease prevention (i.e., in healthy animals considered at risk of infection). These guidelines also recommend that antimicrobials identified as critically important for humans not be used in food-producing animals for treatment or disease control unless susceptibility testing demonstrates the drug to be the only treatment option. Conclusions To preserve the effectiveness of medically important antimicrobials, veterinarians, farmers, regulatory agencies, and all other stakeholders are urged to adopt these recommendations and work towards implementation of these guidelines.

Funder

Ministry of Health, Labour and Welfare

Ministerie van Volksgezondheid, Welzijn en Sport

Publisher

Springer Science and Business Media LLC

Reference28 articles.

1. Eloit M, Graziano da Silva J, Chan M. Super bugs: Why we need action now. Huffington Post. http://www.huffingtonpost.com/dr-monique-eloit/post_13193_b_11992538.html. Accessed 26 Oct 2017.

2. WHO Global Strategy for Containment of Antimicrobial Resistance. World Health Organization, 2001. http://www.who.int/antimicrobial-resistance/publications/WHO_Global_Strategy.htm/en/. Accessed 26 Oct 2017.

3. Molbak K. Human health consequences of antimicrobial rug-resistant salmonella and other foodborne pathogens. Clin Infect Dis. 2005;4:1613–20.

4. WHO Antimicrobial Resistance. Global report on surveillance 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/. Accessed 26 Oct 2017.

5. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2014;10:S122–9. https://doi.org/10.1038/nm1145.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3